Skip to content

A multi-center clinical study on Xiaosheng Powder in the treatment of dry eye with liver depression and Yin deficiency

A multi-center clinical study on Xiaosheng Powder in the treatment of dry eye with liver depression and Yin deficiency

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034675
Enrollment
Unknown
Registered
2020-07-14
Start date
2020-10-01
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Sponsors

Eye Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. It fully meets the diagnostic criteria of western medicine for dry eyes and conforms to the syndrome differentiation of Traditional Chinese medicine for liver depression and Yin deficiency; 2. No serious cardiovascular and cerebrovascular diseases, mental diseases and other patients not suitable for clinical observation; 3. No other treatment received during the observation period; 4. Sign the informed consent form, voluntarily participate in and cooperate with the experimental subjects.

Exclusion criteria

Exclusion criteria: 1. Lactation or serious systemic chronic diseases; 2. Serious abnormal blood routine and liver and kidney function; 3. Congenital no tears, no tear ducts, neurological disorders, such as nerve is paralytic keratitis, lachrymal tube obstruction caused by large area of ocular surface damage, such as heat or chemical eye burn, eyelid defect and other active eye disease (including acute ocular surface inflammation), uncontrolled systemic disease, wearing contact lens, recently has a history of eye surgery or trauma, etc. 4. Use systemic antihistamines, anticholinergic drugs or other ophthalmic drugs that interfere with the efficacy; 5. If the subject considers it inappropriate to conduct a clinical trial; 6. Failure to adhere to treatment.

Design outcomes

Primary

MeasureTime frame
Ocular Surface Disease Index;

Secondary

MeasureTime frame
Tear Break-up Time;Schirmer I test;Fluorescent;OQAS Visual Quality Detector;Levels of Tear Inflammatory Factors;Protein Analysis of Tear Fluid;Quantitative Score Table of TCM Symptoms;

Countries

China

Contacts

Public ContactLike Xie

Eye Hospital, China Academy of Chinese Medical Sciences

bjxielike@sina.com+86 13466782818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026